Table 1.
ID | Age/Gender | dur. | foc. hem. | foc. reg. | szr. type | AED | Nrs | Nsz | d |
---|---|---|---|---|---|---|---|---|---|
1 | 25/f | 20 | Right | Temporal-mesial | CPS | LEV, LTG | 60 | 4 | 175 |
2 | 57/m | 51 | Right | Frontal | CPS | LEV, OXC, TPM | 74 | 5 | 87 |
3 | 52/m | 51 | Left | Temporal-mesial | CPS | LEV, LTG | 44 | 1 | 74 |
4 | 48/f | 34 | Right | Temporal-mesial | – | TPM | 90 | 0 | 327 |
5 | 27/f | 15 | Left | Temporal-mesial | CPS, SG | LEV, LTG | 50 | 2 | 144 |
6 | 13/m | 1 | Left | Parietal | – | LEV | 64 | 0 | 100 |
7 | 37/m | 4 | Right | Temporal-mesial | CPS, SG | LTG | 48 | 4 | 108 |
ID, identification number; gender: f, female and m, male; age and duration (dur.) of epilepsy in years; foc. hem., focal hemisphere; foc. reg., focal region; seizure (szr.) type: CPS, complex partial seizures; SG, secondary generalized seizures; antiepileptic drugs (AED): LEV, levetiracetam; LTG; lamotrigine; OXC, oxcarbazepine; TPM, topiramate; Nrs, number of recording sites; Nsz, number of seizures; d, duration of iEEG recording in hours.